Join Nicki and Jess as they dive into the journey of Clostridioides difficile (C. diff) infections as patients move between hospitals and Skilled Nursing Facilities (SNFs). They’re joined by special guests Kelly, Glenn, and Cory, who help unpack insights from a massive U.S. study of over 86,000 hospitalizations. Together, they explore why so many patients are discharged to SNFs after a C. diff infection, why those coming from SNFs face higher mortality, longer hospital stays, and higher costs, and what this all means for care coordination. Additionally, they break down the stats, discuss the real-world implications, and explain how hospitals and SNFs can work together to improve outcomes for older adults. Tune in for a lively, informative conversation about the challenges and opportunities of navigating care transitions after C. diff.
Guests:
- Kelly R Reveles, PharmD, PhD, Associate Professor, The University of Texas at Austin College of Pharmacy
- Glenn S Tillotson, PhD, Partner, GST Micro
- Cory Evans, OTR/L, CEO, Clinware Solutions, Inc.
Article link: https://www.ajicjournal.org/article/S0196-6553(25)00677-7/fulltext
Kelly Reveles
Kelly Reveles is an Associate Professor at The University of Texas at Austin College of Pharmacy and an Adjoint Associate Professor at The University of Texas Health Science Center at San Antonio School of Medicine. She received her Doctor of Pharmacy and Translational Science PhD degrees from UT Austin. Her current research focus is the prevention and treatment of Clostridioides difficile infections and innovative methods to improve the translation of clinical research findings into practice. Her research approach emphasizes multidisciplinary, collaborative research across the translational spectrum, including basic science, preclinical animal studies, human clinical studies, and pharmacoepidemiology studies. She is specifically interested in identifying and implementing clinical strategies for the prevention and treatment of C. difficile infection using national data, the impact of drugs and diseases on the gut microbiome, and the development of microbiome-targeted therapies to mitigate these effects. She has published over 100 peer-reviewed papers and has been awarded over $5 million in federal grants to support her research.
Glenn Tillotson
Glenn Tillotson is a Partner at GST Micro, a microbiologist consultant to the pharmaceutical and diagnostic industries. He provides support for both medical affairs and commercialization programs for companies, most notably in the infectious disease area. He has had a number of senior roles in the pharmaceutical industry, with over 40 years experience in clinical research, commercialization, and scientific communications, including publications planning, strategic drug development, life cycle management, and global launch programs. Glenn has published over 230 articles; 5 textbook chapters; been a member of several editorial advisory boards, including Lancet Infectious Diseases; has been a member of scientific steering committees for a range of international congresses; and has been involved in several Clostridioides difficile programs. He is a fellow of IDSA and American College of Chest Physicians and is currently Editor-in-Chief of the Expert Review of Anti-Infective Therapy journal.
Cory Evans
Cory Evans is a visionary leader revolutionizing post-acute healthcare through AI-driven innovation, financial optimization, and regulatory excellence. With over 16 years of experience, he has spearheaded advancements in reimbursement strategies, operational efficiency, and compliance-driven care models. As CEO of Clinware Solutions, Inc., Cory leads an AI-powered platform that automates medical documentation analysis, streamlining reimbursement processes, reducing administrative burdens, and enhancing care coordination for healthcare facilities. Under his leadership, Clinware Solutions is expanding its partnerships with hospital systems, skilled nursing facilities (SNFs), and healthcare networks, driving the adoption of AI-driven reimbursement optimization and seamless electronic health record (EHR) integration, which supports SNFs and hospital systems. His expertise in healthcare operations, strategic leadership, and technology-driven solutions positions Clinware Solutions as a premier AI-powered healthcare platform, delivering measurable improvements in reimbursement efficiency and patient care outcomes. Throughout his career, Cory has strengthened Medicare and Medicaid reimbursement strategies, increasing financial efficiency across post-acute care providers. He has led seamless EHR transitions to modern platforms, ensuring workflow efficiency and compliance while reducing administrative costs. His leadership in care coordination has led to a 50% reduction in hospital readmissions through the implementation of evidence-based protocols and strategic collaboration. Prior to Clinware Solutions, Cory held leadership roles in compliance, business development, and operational strategy, overseeing clinical operations, therapy services, and interdisciplinary collaboration to ensure seamless care delivery and optimized reimbursement models. His leadership ensures adherence to HIPAA, SOC 1, SOC 2, and Medicare regulations, reinforcing trust in healthcare data management while driving scalable financial growth. Cory holds a Bachelor of Science in Occupational Therapy from Keuka College and maintains certifications as an Occupational Therapist (OTR/L) and Resident Assessment Coordinator – Certified (RAC-CT). He is an active member of NCBOT, NBCOT, and AAPACN, contributing to advancements in post-acute care standards, regulatory compliance, and interdisciplinary collaboration. Cory is committed to advancing AI-driven healthcare solutions that enhance provider performance and strengthen financial outcomes for healthcare organizations.